CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 35.70
+0.30 (0.85%)
Jan 21, 2026, 4:08 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 13.18 billion as of January 21, 2026. Its market cap has increased by 16.76% in one year.
Market Cap
13.18B
Enterprise Value
11.69B
Revenue
1.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
35.70
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 13.18B, an increase of 74.09%. That is a compound annual growth rate of 8.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 13.18B | 4.35% |
| Dec 31, 2025 | 12.63B | 8.81% |
| Dec 31, 2024 | 11.61B | -7.23% |
| Dec 29, 2023 | 12.51B | -54.81% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The United Laboratories International Holdings | 22.85B |
| Ab&B Bio-Tech CO., LTD. JS | 18.79B |
| Consun Pharmaceutical Group | 14.39B |
| CF PharmTech | 13.69B |
| Sihuan Pharmaceutical Holdings Group | 11.62B |
| Luye Pharma Group | 11.42B |
| China Traditional Chinese Medicine Holdings Co. | 10.83B |
| Shandong Xinhua Pharmaceutical Company | 10.48B |